Qiagen N.V. Beat Consensus Estimates

Qiagen N.V. (QGEN) reported earnings of $0.55 per share on revenue of $483.46 million for the first quarter ended March 2025. The consensus earnings estimate was $0.50 per share on revenue of $464.10 million. The company beat consensus estimates by 10.00% while revenue grew 5.37% on a year-over-year basis.

The company said it continues to expect 2025 earnings of approximately $2.35 per share. The current consensus earnings estimate is $2.30 per share for the year ending December 31, 2025.

Qiagen NV provides sample and assay technologies. It also offers kits, assays, related automated systems and bioinformatics solutions, that cover the entire continuum from basic life sciences research to clinical diagnostics.